Creating better bar food
Chris Ferguson left the business world to venture into food. Now he’s the founder and owner of Bee’s Knees, providing gourmet bar snacks that pair well with craft beers.
Study sheds light on parasite that causes river blindness
The parasite that causes river blindness infects about 37 million people in parts of Africa and Latin America, causing blindness and other major eye and skin diseases in about 5 million of them. A study from the School of Medicine sheds light on the genetic makeup of the parasite, a step toward the goal of eradication.
New topical immunotherapy effective against early skin cancer
A combination of two topical drugs that have been in use for years triggers a robust immune response against precancerous skin lesions, according to a new study. The research, from the School of Medicine and Harvard Medical School, shows that the therapy activates the immune system’s T cells, which then attack the abnormal skin cells. The study was published Nov. 21 in The Journal of Clinical Investigation.
Weight loss may help prevent multiple myeloma
New research at the School of Medicine shows that excess weight increases the risk that a benign blood disorder — called monoclonal gammopathy of undetermined significance — will progress into multiple myeloma, a cancer of the blood.
Investing $25 million in imaging sciences
Washington University in St. Louis is launching a bold $25 million initiative over the next five years to develop innovative technologies aimed at improving science and medicine worldwide. The Imaging Sciences Initiative – a partnership between the School of Engineering & Applied Science and the School of Medicine – will support the development of new imaging technologies to diagnose and treat disease as well as study intricate biological structures, metabolism and physiology, and critical molecular and cellular processes.
National trial to assess drugs for severe seizures
A national clinical trial involving Washington University physicians at St. Louis Children’s Hospital will compare three commonly used anti-seizure medications used to treat seizures that last over five minutes and don’t respond to initial treatment. Such seizures can strike anyone but are most common in people already diagnosed with epilepsy.
Researchers launch first clinical trial for Wolfram syndrome
Researchers at Washington University School of Medicine in St. Louis are launching a new clinical trial to assess the safety of a drug treatment for patients with the rare disease Wolfram syndrome.
WashU Expert: Talking to your kids about election outcome
If adults are feeling anxious, depressed or angry about the presidential election results, their children might be feeling the same. Joan Luby, MD, the Samuel and Mae S. Ludwig Professor of Child Psychiatry at the School of Medicine, offers advice to parents on what they can say to their children who are expressing anxiety or sadness.
Election 2016 from Washington University’s view
At a transformative moment in our nation’s history, when America’s “Brexit vote” came to pass, where better than Washington University to bring together the thought leaders and experts from disparate fields covering the littered landscape that was, is and forever will be Election 2016?
New technique aids search for genetic roots of disease
Researchers at the School of Medicine have developed a new technique to cheaply and rapidly create myriad sets of DNA fragments that detail all possible genetic variants in a particular stretch of DNA. By studying such DNA fragments, scientists can more easily distinguish between genetic variants linked to disease and those that are innocuous.
Older Stories